Aurora Health Care’s nationally ranked cardiology and cardiovascular program offers some of the best available care. Through clinical trials, we are shaping the next generation of treatments – new options for longer-lasting results and ultimately, healthy and happy people.
More than 500 subjects participated in Aurora’s cardiology and cardiovascular clinical trials in 2016 alone. This depth of diverse data is one reason why leading medical device and drug companies trust us to study their products. In turn, people have access to even more treatment options than ever before.
Highlights of our program include:
New treatments are first developed in the labs of medical device and pharmaceutical (drug) companies. After the treatments pass initial safety tests, Aurora collaborates with these companies to study the treatments through participation in clinical trials.
Clinical trials include a series of phases exploring the safety and effectiveness of new treatments. Each phase answers a different question about how a treatment might work in different groups of people. Read more about clinical trials participant information.
Our work spans the full range of heart and vascular disease treatments, including medications, devices and nonsurgical techniques.
Our research interests include: